|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
3/1/21 Sarepta Therapeutics, Inc. 10-K 12/31/20 124:22M ActiveDisclosure/FA
2/12/21 Barry Richard 5 Director² 1:4K Sarepta Therapeutics, Inc. DONNELLEY FIN… File16/FA
1/4/21 Ingram Douglas S 4 Dir.,Off.² 1:5K Sarepta Therapeutics, Inc. DONNELLEY FIN… File16/FA
____________ | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 5 | Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 { The Filer is an Insider² of the Issuer }. | | 10-K | Annual Report — Form 10-K. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|